BTAIVSCRL• 28 Days (Normalized)
BTAI vs CRL (BioXcel Therapeutics Inc. vs Charles River Laboratories International Inc.)
Showing Closing Date Range from Sep 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
CRL Performance $290.19
+3.36%
Charles River Laboratories International Inc.
Normalized Baseline0.00%
Alpha Spread Margin CRL LEADS
-3.36 pts
CRL outperforming by 3.36 percentage points
BTAICRL
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI CRL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | BTAI Price | BTAI Gain (%) | CRL Price | CRL Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $- | $290.19 | +3.36% | - | |
| Oct 01, 2026 | $- | $286.83 | +2.16% | - | |
| Sep 30, 2026 | $- | $295.01 | +5.08% | - | |
| Sep 29, 2026 | $- | $295.96 | +5.41% | - | |
| Sep 28, 2026 | $- | $294.59 | +4.93% | - | |
| Sep 25, 2026 | $- | $292.84 | +4.30% | - | |
| Sep 24, 2026 | $0.04 | -17.91% | $- | - | |
| Sep 23, 2026 | $0.05 | +4.65% | $277.33 | -1.22% | +5.87% |
| Sep 22, 2026 | $0.04 | +3.72% | $285.11 | +1.55% | +2.17% |
| Sep 21, 2026 | $0.06 | +43.02% | $279.01 | -0.62% | +43.64% |
| Sep 18, 2026 | $0.06 | +34.88% | $278.06 | -0.96% | +35.84% |
| Sep 17, 2026 | $0.08 | +74.65% | $281.67 | +0.32% | +74.33% |
| Sep 16, 2026 | $0.07 | +55.58% | $273.41 | -2.62% | +58.20% |
| Sep 15, 2026 | $0.04 | +3.95% | $272.88 | -2.81% | +6.76% |
| Sep 14, 2026 | $0.05 | +4.88% | $273.11 | -2.72% | +7.60% |
Page 1 of 2